NVAXNovavax, Inc.$10.32Citigroup
RatingSell unchanged
Price target$7 → $8 +14.3% · +$1
Price at note$12.82 (Oct 15 close) −37.6% downside (−$4.82) to the $8 target
Third-party analyst actions
Analyst moves
Upgrades, downgrades, new coverage and price-target changes from Wall Street firms on the stocks we cover. What each firm published, laid out plainly. These are third-party actions, not our views.
Showing every move on file for NVAXClear search
30 moves
ⓘ Rating colors
- Strong BuyConviction Buy, Top Pick, Top Pick Buy
- BuyLong Term Buy, Speculative Buy, Outright Buy
- OutperformOverweight, Accumulate, Moderate Buy, Positive
- HoldNeutral, Equal Weight, Market Perform, Sector Perform
- UnderperformUnderweight, Reduce, Moderate Sell, Negative
- Sell
- Strong Sell
- OtherRatings we can't place on the scale
Each firm's own wording is placed on one seven-step scale so ratings compare at a glance. ▲ / ▼ between two ratings marks an upgrade or a downgrade. The colours describe what the firm said; they are not our view.
Thursday · Oct 15, 2026
NVAXNovavax, Inc.$10.32Thursday · Jun 11, 2026
NVAXNovavax, Inc.$10.32BTIG
RatingBuy unchanged
Price target$19 unchanged
Wednesday · May 6, 2026
NVAXNovavax, Inc.$10.32TD Cowen
RatingHold unchanged
Price target$8 → $9 +12.5% · +$1
Friday · Feb 27, 2026
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$11 → $16 +45.5% · +$5
Tuesday · Jan 20, 2026
NVAXNovavax, Inc.$10.32BTIG
RatingBuy unchanged
Price target$19 unchanged
Tuesday · Nov 18, 2025
NVAXNovavax, Inc.$10.32JP Morgan
RatingUnderweight unchanged
Price target$7 → $6 −14.3% · −$1
Monday · Nov 10, 2025
NVAXNovavax, Inc.$10.32B. Riley Securities
RatingBuy unchanged
Price target$18 → $16 −11.1% · −$2
Tuesday · Nov 4, 2025
NVAXNovavax, Inc.$10.32TD Cowen
RatingHold unchanged
Price target$8 → $7 −12.5% · −$1
Friday · Oct 24, 2025
NVAXNovavax, Inc.$10.32Cantor Fitzgerald
RatingOverweight Initiated
Price target$18
Thursday · Oct 23, 2025
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$10 → $11 +10.0% · +$1
Wednesday · Aug 20, 2025
NVAXNovavax, Inc.$10.32B of A Securities
RatingNeutral▼Underperform
Price target$9 → $7 −22.2% · −$2
Tuesday · Jul 22, 2025
NVAXNovavax, Inc.$10.32B of A Securities
RatingNeutral unchanged
Price target$10 → $9 −10.0% · −$1
Tuesday · Jun 17, 2025
NVAXNovavax, Inc.$10.32Citigroup
RatingSell Initiated
Price target$6
Friday · May 9, 2025
NVAXNovavax, Inc.$10.32JP Morgan
RatingUnderweight unchanged
Price target$9 → $7 −22.2% · −$2
Tuesday · Dec 10, 2024
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$19 unchanged
Wednesday · Nov 13, 2024
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$19 unchanged
Tuesday · Nov 12, 2024
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$19 unchanged
Monday · Aug 12, 2024
NVAXNovavax, Inc.$10.32B. Riley Securities
RatingBuy unchanged
Price target$25 → $23 −8.0% · −$2
NVAXNovavax, Inc.$10.32JP Morgan
RatingUnderweight unchanged
Price target$8 → $9 +12.5% · +$1
Friday · Aug 2, 2024
NVAXNovavax, Inc.$10.32B. Riley Securities
RatingBuy unchanged
Price target$29 → $25 −13.8% · −$4
Tuesday · Jul 30, 2024
NVAXNovavax, Inc.$10.32JP Morgan
RatingNeutral▼Underweight
Price target$8
Friday · Jun 14, 2024
NVAXNovavax, Inc.$10.32B of A Securities
RatingNeutral unchanged
Price target$12 → $18 +50.0% · +$6
Thursday · May 23, 2024
NVAXNovavax, Inc.$10.32B. Riley Securities
RatingBuy unchanged
Price target$11 → $29 +163.6% · +$18
Monday · May 13, 2024
NVAXNovavax, Inc.$10.32TD Cowen
RatingHold unchanged
Price target$5 → $10 +100.0% · +$5
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$19 unchanged
Friday · May 10, 2024
NVAXNovavax, Inc.$10.32B of A Securities
RatingUnderperform▲Neutral
Price target$4 → $12 +200.0% · +$8
Friday · Mar 1, 2024
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$35 → $19 −45.7% · −$16
Friday · Feb 23, 2024
NVAXNovavax, Inc.$10.32B. Riley Securities
RatingBuy unchanged
Price target$12 → $11 −8.3% · −$1
Thursday · Aug 10, 2023
NVAXNovavax, Inc.$10.32HC Wainwright & Co.
RatingBuy unchanged
Price target$35
Wednesday · Aug 9, 2023
NVAXNovavax, Inc.$10.32B. Riley Securities
RatingNeutral▲Buy
Price target$15
Source: Yahoo Finance analyst upgrades and downgrades (firm, rating, price target), refreshed after each US market close for the stocks SURVYR. covers. Yahoo doesn't name the individual analyst. "Price at note" is that day's closing price from our daily price history (the prior close when the note came before the open); the upside or downside is the distance from it to the new target. Details opens the matching news story when we have one, otherwise the stock's Yahoo Finance analysis page. Ratings and targets belong to the firms named; SURVYR. doesn't rate stocks, set targets or give advice. Not investment advice · Important disclosures
Get the market emails
Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdaysIndexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.
Check your inbox to confirm
We sent a link to . Tap it to start your emails. Nothing is sent until you confirm.
Not there in a minute? Check spam, or .
Dev mode No email provider here, so the confirm link is shown: Open confirm link
SURVYR
Free to use. No card, no ads, no auto-renew.
Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Coteau 0.9 · Oct 21, 2026